Abcuro announces pre-clinical data on new immuno-oncology target
Member News

Related or similar articles

May 6, 2025
How AI is Revolutionizing Biotech—and Why Labshares Remains the Ideal Home for Emerging Biotechs
AI is transforming biotech by accelerating drug discovery, diagnostics, and research. Emerging AI-biotech companies still need flexible wet lab space, advanced equipment, and experimental validation to bring discoveries to market.
Blog Posts

December 10, 2021
Labshares Newton Doubles Space for Emerging Biotech Startups
Labshares Newton celebrated today the opening of 19,000 square feet of new incubator lab space and expects to open another 6,000-foot lab in September. Labshares’ new space incorporates 12 private lab suites and 15 benches.
Labshares News
